Q2i Partners with MaineHealth to Implement SIMS Technology for Contingency Management in Stimulant Use Treatment

Q2i is proud to announce a partnership with MaineHealth aimed at enhancing treatment for stimulant use through the implementation of its SIMS technology. This collaboration focuses on contingency management, an evidence-based practice that has gained recognition for its effectiveness in substance use treatment.

Overview of SIMS Technology

The SIMS (Substance Intervention Management System) technology allows clinicians to efficiently manage and monitor patients' progress and outcomes in stimulant use treatment. It empowers providers with data-driven insights to personalize care and improve treatment effectiveness.

Objectives of the Partnership

• Enhance Treatment Options: Integrate innovative solutions to support stimulant use treatment.
• Improve Patient Outcomes: Utilize SIMS technology to track and encourage positive patient behaviors.
• Collaborative Training: Provide training for healthcare providers on using the new technology effectively.

Benefits to Patients

Patients will have access to tailored treatment plans that incorporate real-time data and feedback, promoting accountability and supporting recovery.

About Q2i

Q2i focuses on integrating advanced technological solutions to enhance behavioral health treatment, striving for better outcomes across various substance use disorders.